PMV Pharma(PMVP)
PRINCETON, NJPharmaceutical
Focus: PMV Pharma is a publicly traded oncology-focused biotech specializing in p53 regulators, a novel approach to restoring tumor suppressor function in cancer. The company operates at mid-scale with 201-500 employees and is advancing multiple programs toward regulatory submissions.
Profile data last refreshed 12h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Employees
201-500
Open Jobs
0
About PMV Pharma
AI assessmentNot HiringNo open roles listed right now. Follow PMV Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from PMV Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
PC14586
Healthy VolunteersClinical Trials (1)
NCT06362642A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of PC14586 in Healthy Participants
Phase 1Help build intelligence for PMV Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.